Department of Exact and Technological Sciences, State University of Santa Cruz, Ilhéus, Brazil.
Department of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
J Microencapsul. 2023 Mar;40(2):67-81. doi: 10.1080/02652048.2023.2172469. Epub 2023 Feb 13.
The objectives of this work are to develop nanocarrier systems for the Ru(II)-p-cymene naproxen antitumor metallodrug, [Ru(η-p-cymene)(npx)Cl] or Rupcy, based on polymeric nanoparticles (NPs) composed by the biodegradable poly(lactic acid) (PLA) and the hydrophilic polymerised β-cyclodextrin (PolyCD); to validate an analytical method for determination of Ru incorporated into the metallodrug loaded-NPs. The PolyCD was prepared by single step condensation and polymerisation reaction and incorporated as a polymer blend during the fabrication of PLA/PolyCD blends NPs and also as a core/shell structure built by adsorption of the PolyCD onto the surface of PLA NPs to give PLA(core)/PolyCD(shell) NPs. Three different loaded-systems incorporating the metallodrug (Rupcy-PLA NPs (), Rupcy-PLA/PolyCD blends (), and Rupcy-PLA(core)/PolyCD(shell) NPs ()) were prepared by nanoprecipitation. The characterisation was performed by Proton Nuclear Magnetic Resonance, Matrix Assisted Laser Desorption/Ionization Time-of-Flight, Fourier-Transform Infra-red and UV-VIS Electronic Absorption Spectroscopies, Thermogravimetric Analysis, Differential Scanning Calorimetry, Dynamic Light Scattering, and Electrophoretic Light Scattering. Ru was determined by Microwave Induced Plasma Optical Emission Spectrometry (MIP-OES) with validation of the method. The metallodrug entrapment efficiency was around 90% (w/w) and drug loading was at 3-4% (w/w). The characterised metallodrug-loaded systems exhibited monomodal size distributions and appropriate hydrodynamic diameters [218.3 ± 13.5 (), 205.4 ± 14.4 (), 231.5 ± 22.0 () nm] and zeta potential values [-31.5 ± 2.2 (), -26.1 ± 4.5 (), -28.8 ± 6.1 () mV]. The validation of the MIP-OES method by evaluating selectivity, linearity, precision, accuracy, and limits of detection and quantification succeeded. The NPs parameters are compatible with colloidally stable systems. The MIP-OES method showed to be simple, reliable, and feasible to quantify indirectly the amount of the metallodrug-loaded into the PLA NPs.
这项工作的目标是开发基于纳米载体系统的 Ru(II)-p-薄荷烯萘普生抗肿瘤金属药物[Ru(η-p-薄荷烯)(npx)Cl]或 Rupcy,该系统由可生物降解的聚乳酸(PLA)和水溶性聚合物β-环糊精(PolyCD)组成的聚合物纳米粒子(NPs)组成;验证一种分析方法,用于测定金属药物负载 NPs 中 Ru 的含量。PolyCD 通过单步缩合和聚合反应制备,并在制备 PLA/PolyCD 共混物 NPs 时作为聚合物共混物掺入,也作为通过吸附 PolyCD 到 PLA NPs 表面构建的核/壳结构掺入,得到 PLA(核)/PolyCD(壳)NPs。通过纳米沉淀法制备了三种不同的负载系统,包括金属药物(Rupcy-PLA NPs ()、Rupcy-PLA/PolyCD 共混物 () 和 Rupcy-PLA(core)/PolyCD(shell) NPs ())。通过质子核磁共振、基质辅助激光解吸/离子化飞行时间、傅里叶变换红外和紫外可见电子吸收光谱、热重分析、差示扫描量热法、动态光散射和电泳光散射进行了表征。通过微波诱导等离子体光发射光谱(MIP-OES)测定 Ru,并验证了该方法。金属药物包封效率约为 90%(w/w),药物载量为 3-4%(w/w)。所表征的金属药物负载系统表现出单模态尺寸分布和适当的流体力学直径[218.3 ± 13.5 ()、205.4 ± 14.4 ()、231.5 ± 22.0 ()nm]和 ζ 电位值[-31.5 ± 2.2 ()、-26.1 ± 4.5 ()、-28.8 ± 6.1 ()mV]。通过评价选择性、线性、精密度、准确度和检测限和定量限,成功验证了 MIP-OES 方法的验证。NPs 参数与胶体稳定系统兼容。MIP-OES 方法简单、可靠、可行,可间接定量测定负载到 PLA NPs 中的金属药物量。